Please sign this petition & share with everyone you know. Radiotherapy damage causes accelerated dental problems which we have to pay for. It is not covered by the NHS. It has cost me & others thousands ££££’s over the years. Your support is appreciated 👍 https://t.co/5xeTGZil9v
Fantastic recruitment by the Addenbrookes team @entcambridge! Well done for recruiting 5 patients to the @PETNECK2 study, within 1 month of activation!
So far 188 registrations, of which 155 patients randomised. Calling out to all our NHS sites for accelerating recruitment!
Another two sites activated this month! Thank you Castle Hill research team @huthresearch and Queen Elizabeth University Hospital team @GlasgowCRF for your hard work. We wish you best of luck for recruitment for @PETNECK2.
Pleased to have 56 patients recruited!
Congratulations to Dr Dinos Geropantas and his team at @NNUH for recruiting their first patient to the feasibility study. This takes our recruitment number to 14!!! @PaulNankivell,@h_mehanna,@CRCTU, @InhanseResearch
What better day to enroll the first patient in @PETNECK2 than the International Clinical Trial day. Very excited for @NHSGrampian to contribute to this excellent piece of research by @h_mehanna and @PaulNankivell. #ICTD2022
And we're off! A significant milestone for @PETNECK2 and congratulations to Aberdeen @NHSGrampian for leading the way as the first site open to recruitment
Congratulations to Oxford University Hospitals @OUH_HeadandNeck- our third site open to recruitment for PETNECK2!! Thank you to the PI @Stuart_C_Winter and his research team for their hard work in study set-up. We wish you all the best for recruitment!!
@h_mehanna@PaulNankivell
@QuinteTBristol, @PaulNankivell, @h_mehanna The PETNECK2 trial will compare a new model of patient-initiated follow-up (PIFU) with routine scheduled follow-up. What are UK clinicians' views about HNC follow-up and PIFU? To find out, read our article https://t.co/JAUsnno5lS